|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||0.00 / 0.00|
Martek plunges 44% after warning that third-quarter sales would be below expectations.
Charlotte Russe, Adtran and others look like good reversal candidates on any market strength.
But the index has a lot of ground to make up. Plus survey results, Geron and more.
Shares working with other companies on a treatment for wet macular degeneration gain.
Analysts say the company's eye treatment has a good chance of getting FDA approval.
Its shares have soared on the promise of its new drug, making this week's FDA panel key.
While not a risk-free strategy, trading stocks that have broken a range can pay off.
The proceeds will be used for research and development.
Visudyne's success hinges on doctors buying pricey equipment.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.